Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 1214717 BOSTON, MA
Back to GLSI Full portfolio

Position in GLSI

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$3,945,479
+$211,187 QoQ
Shares Held
168,179
+8.2% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 57 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GLSI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. GLSI ranks #263 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in GLSI

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,945,479 168,179
2026-03-31 $3,734,292 155,466
2025-12-31 $3,186,880 151,684
2025-09-30 $1,414,053 142,116
2025-06-30 $1,260,566 138,982
2025-03-31 $1,307,075 137,010
2024-12-31 $1,505,616 134,071
2024-09-30 $1,919,113 133,550
2024-06-30 $2,203,911 127,689
2024-03-31 $1,161,385 58,244
2023-12-31 $492,504 46,816
2023-09-30 $407,453 46,092
2023-06-30 $385,153 39,933
2023-03-31 $550,676 39,933
2022-12-31 $606,981 39,933
2022-09-30 $384,556 42,259
2022-06-30 $347,092 40,979
2022-03-31 $1,367,749 69,712
2021-12-31 $1,640,328 67,420
2021-09-30 $2,223,825 56,919
2021-06-30 $2,354,631 52,395
2021-03-31 $493,043 14,463
2020-12-31 $256,019 7,020